Adulteration

Duffy MacKay highlighted Amazon’s updated testing policy, noting that he believes it will have a significant impact on the availability of products containing drugs, such as tianeptine, a substance with opioid-like effects that is being falsely marketed and sold in gas stations and online as a dietary supplement.

CHPA’s MacKay on Amazon policy: ‘The retailers are watching’

By Danielle Masterson

The recent Consumer Healthcare Products Association’s Regulatory, Scientific & Quality (RSQ) Conference brought together leaders from across the consumer healthcare landscape to discuss issues that are facing the industry and find solutions to some...

JAMA paper on botanical use and liver damage draws criticism

JAMA paper on botanical use and potential liver damage draws criticism

By Asia Sherman

A paper published this week in the JAMA Network Open medical journal spotlights the use of six herbal supplements frequently associated with potential hepatotoxic effects. The reliability of the data, approach, conclusions and call to action quickly came...

NutraCast: Mushrooms from China? Why Nammex says yes

NutraCast: Mushrooms from China? Why Nammex says yes

By Danielle Masterson

China has a rich tradition of growing, cultivating, studying and using mushrooms in Traditional Chinese Medicine. Deep-rooted expertise, historical background and substantial research contribute to a profound comprehension of mushroom chemistry and biology....

© Juxtagirl / Getty Images

New paper explores issue of excessive dilution of botanical extracts

By Stephen Daniells

A new HerbalGram article shines a light on the excessive use of excipients with botanical extracts—also known as fairy dusting. “This is about hopefully changing the practice of some members of industry to give consumers the product they expect,” said...

Purity-IQ launches new tool to authenticate mushroom products

Purity-IQ launches new tool to authenticate mushroom products

By Danielle Masterson

They're in coffee, skincare, various gummies and inescapable at SupplySide West. Mushrooms are popping up everywhere. While there is a lot of enthusiasm around mushrooms, there's also a good amount of skepticism. That's where Purity-IQ...

© evgenyb / Getty Images

SSW education session to spotlight ‘historic’ BAPP SOP

By Stephen Daniells

Stakeholders can learn how to implement the BAPP ‘Burn it, Don’t return it’ SOP to help ensure the integrity of the worldwide supply chain for dietary supplements, foods, OTC drugs, and cosmetics.

Image courtesy of CRN

Califf and Mister talk: Top 6 takeaways

By Danielle Masterson

Making several references to sports, Califf talked transparency, innovation, MPLs, CBD and more. But did he drop the ball or knock it out of the park?

Getty images / Monty Rakusen

Herbalife’s DNA-based botanical authentication program

By Danielle Masterson

For Herbalife’s Zhengfei Lu, PhD, the importance of botanical authentication goes beyond fulfilling the regulatory requirement on botanical identification– it’s about protecting consumers, ensuring efficacy and supporting sustainable practices.

Rhodiola rosea: Adjusting to life as an endangered species

Rhodiola rosea: Adjusting to life as an endangered species

By Asia Sherman

The global demand for Rhodiola rosea – also known as "golden root" or "roseroot" – has been increasing steadily since the late 20th century, so much so that it now faces restrictions in international trade brought on by exploitative...

Fungi Perfecti responds to ‘puzzling opinion’ in Nammex petition

Fungi Perfecti responds to ‘puzzling opinion’ in Nammex petition

By Asia Sherman

Fungi Perfecti, a supplier of mycelium-based supplements, has written an open letter to address the citizen petition filed by mushroom extract company Nammex, which requested that the Food and Drug Administration act to ensure proper labeling of fungi...

FDA: SARMs not worth the health risk ‘for a few extra likes’

FDA: SARMs not worth the health risk ‘for a few extra likes’

By Asia Sherman

The U.S. Food and Drug Administration (FDA) issued an advisory this week warning of adverse event reports related to selective androgen receptor modulators (SARMs). In the letter, the agency also takes issue with online vendors and social media influencers...

Follow us

Products

View more

Webinars